Marshall Fordyce
2020
In 2020, Marshall Fordyce earned a total compensation of $3.2M as President and Chief Executive Officer at Vera Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $108,000 |
|---|---|
| Option Awards | $2,441,982 |
| Salary | $360,000 |
| Stock Awards | $316,323 |
| Total | $3,226,305 |
Fordyce received $2.4M in option awards, accounting for 76% of the total pay in 2020.
Fordyce also received $108K in non-equity incentive plan, $360K in salary and $316.3K in stock awards.
Rankings
In 2020, Marshall Fordyce's compensation ranked 3,610th out of 13,090 executives tracked by ExecPay. In other words, Fordyce earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,610 out of 13,090 | 72nd |
Division Manufacturing | 1,413 out of 5,624 | 75th |
Major group Chemicals And Allied Products | 531 out of 2,257 | 77th |
Industry group Drugs | 461 out of 1,957 | 76th |
Industry Pharmaceutical Preparations | 347 out of 1,462 | 76th |
Source: SEC filing on April 14, 2022.